# EDGAR Filing Document

**Accession Number:** 0001610820
**File Stem:** 0001641172-25-019540
**Filing Date:** 2025-7
**Character Count:** 2540
**Document Hash:** 6b20a08737dffd5909db397ccbe451a6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-019540.hdr.sgml**: 20250812

**ACCESSION NUMBER**: 0001641172-25-019540

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250714

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BriaCell Therapeutics Corp.
- **CENTRAL INDEX KEY:** 0001610820
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 0731

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR
- **CITY:** WEST VANCOUVER
- **STATE:** A1
- **ZIP:** V7T 2X1
- **BUSINESS PHONE:** (604) 921-1810

**MAIL ADDRESS:**
- **STREET 1:** 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR
- **CITY:** WEST VANCOUVER
- **STATE:** A1
- **ZIP:** V7T 2X1

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Ansell Capital Corp.
- **DATE OF NAME CHANGE:** 20140613

**ThinkEquity LLC**

17 State Street, 41<sup>st</sup> Floor

New York, NY 10004

July 14, 2025

**VIA EDGAR**

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street NE

Washington, D.C. 20549

Attention: Alan Campbell

---

| | |
|:---|:---|
| **Re:** | **BriaCell Therapeutics Corp. (the "Company")** |
|  | **Registration Statement on Form S-1 (the "Registration Statement")** |
|  | **File No. 333-288562** |

---

Ladies and Gentlemen:

ThinkEquity LLC ("ThinkEquity") hereby concurs in the request by the Company to withdraw its request for an accelerated effective date of the above-referenced Registration Statement to 9:00 a.m. Eastern Time on July 14, 2025, or as soon as practicable thereafter.

In addition, ThinkEquity, solely acting as placement agent on a best efforts basis in an offering pursuant to the Registration Statement, hereby concurs in the request by the Company that the effective date of the above-referenced Registration Statement be accelerated to 5:00 p.m. Eastern Time on July 15, 2025, or as soon as practicable thereafter, unless the Company notifies you otherwise prior to such time pursuant to Rule 461 under the Securities Act of 1933 (the "Securities Act").

ThinkEquity affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

---

| |
|:---|
| Very truly yours, |
| **ThinkEquity LLC** |
| */s/ Eric Lord* |
| Eric Lord |
| Head of Investment Banking |

---